First Trust Advisors’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-17,971
Closed -$541K 2499
2016
Q3
$541K Buy
+17,971
New +$494K ﹤0.01% 1980
2016
Q1
Sell
-22,638
Closed -$459K 2281
2015
Q4
$459K Sell
22,638
-4,351
-16% -$92.4K ﹤0.01% 2002
2015
Q3
$589K Sell
26,989
-33,188
-55% -$779K ﹤0.01% 1924
2015
Q2
$1.41M Buy
60,177
+23,923
+66% +$600K ﹤0.01% 1676
2015
Q1
$944K Buy
+36,254
New +$864K ﹤0.01% 1779
2014
Q1
Sell
-264,384
Closed -$6.45M 2312
2013
Q4
$6.45M Sell
264,384
-9,386
-3% -$221K 0.03% 830
2013
Q3
$6.51M Sell
273,770
-9,830
-3% -$211K 0.04% 733
2013
Q2
$5.67M Buy
+283,600
New +$7.1M 0.04% 702

Other funds holding SRDX

First Trust Advisors's SRDX Position: Q4 2016 in Review

First Trust Advisors sold out of Surmodics (SRDX) in Q4 2016, closing a stake of 17,971 shares — an estimated $541K sold.

First Trust Advisors first reported a position in SRDX in Q2 2013 and held it in 8 quarters. The position peaked at $6.51M in Q3 2013. 116 funds tracked by Wall St. Rank hold SRDX as of Q4 2016.

  • First Trust Advisors reported no remaining Surmodics position as of Q4 2016 after selling out during the quarter.
  • First Trust Advisors sold 17,971 Surmodics shares in Q4 2016, an estimated $541K.
  • First Trust Advisors first reported a position in Surmodics in Q2 2013 and held it in 8 quarters.
  • First Trust Advisors's Surmodics position peaked at $6.51M in Q3 2013.
  • 116 funds tracked by Wall St. Rank held Surmodics as of Q4 2016.

Based on First Trust Advisors's 13F filing for Q4 2016, filed 6 Feb 2017.